In this episode of Diabetics Doing Things, Rob interviews Brian Connelly from TheracosBio. Brian shares insights into his background, the mission of Theracos, and their breakthrough SGLT 2 inhibitor, Brenzavvy. The discussion delves into Brian's journey to Theracos, his work in the biotech industry, and the mission of Theracos to provide affordable medications for patients with common diseases, like type 2 diabetes.
Topics discussed:
1. Brian Connelly's background and journey to TheracosBio.
2. The mission of TheracosBio to develop affordable medications for patients with chronic diseases.
3. Introduction to Theracos' breakthrough SGLT 2 inhibitor, Brenzavvy.
4. Challenges in the pharmaceutical industry regarding drug pricing and accessibility.
5. Impact of Brenzavvy on patients with type 2 diabetes, focusing on cost, efficacy, and improved health outcomes.
6. Distribution and accessibility of Brenzavvy through Cost Plus Drugs and traditional pharmacies.
7. The importance of alignment within the organization and the societal impact of providing affordable medications.
8. Addressing public health concerns, adherence rates, and long-term cost savings for patients with chronic conditions.
Here are key takeaways and lessons:
- TheracosBio is dedicated to providing affordable medications, like Brenzavvy, to patients with chronic diseases, such as type 2 diabetes.
- Brenzavvy offers cost-effective treatment options with improved health outcomes for patients.- Share struggles to create awareness and support within the community.
- The company's mission prioritizes patient access and affordability over maximizing profits, emphasizing societal impact and improved public health.
- Collaboration with organizations like Cost Plus Drugs enhances distribution and accessibility of Brenzavvy to a wider patient population.
- The importance of transparency, patient feedback, and physician awareness in promoting the use of affordable medications for chronic conditions.
References:
00:00: Unveiling the Noble Mission of TheracosBio: A Journey from Feline Diabetes to Human Therapeutics
05:59: Finding Purpose Through Chronic Illness and Work: A Journey of Passion and Perseverance
13:02: Revolutionizing Drug Pricing: The Mission of Theracos in Making Medication Accessible
19:37: Exploring the High Cost of Diabetes Medication and Solutions
24:28: Addressing Societal Impact and Accessibility in Diabetes Treatment
29:16: Challenges and Misconceptions in the Pharmaceutical Industry
33:45: Building a Mission-Driven Company: The Journey of Theracos CEO
37:57: Revolutionizing Access to Medication: The Success Story of Brenzavvy
40:58: Unveiling Brenzavvy: The Affordable and Effective SGLT 2 Inhibitor for Type 2 Diabetes
45:06: Revolutionizing Healthcare with Low Cost Drugs: A Story of Passion and Purpose
